Bruce N. Jacobs
Chief Financial Officer · 3 filings · Latest: Jun 2, 2026
Kymera Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KYMR | BRUCE N. JACOBS | — | Jun 30, 2026 | Proposed Sale | $109.32 | 77,109 | $8.4M | — | |
KYMR | Bruce N. Jacobs | Chief Financial Officer | Jun 2, 2026 | Option Exercise | $2.08 | 12,653 | $26.3K | 260,241 | |
KYMR | Bruce N. Jacobs | Chief Financial Officer | May 18, 2026 | Option Exercise | $2.08 | 15,000 | $31.2K | 247,588 | |
KYMR | Bruce N. Jacobs | Chief Financial Officer | Mar 4, 2026 | Sale | $85.30 | 4,895 | $417.5K | 232,588 | |
KYMR | Bruce N. Jacobs | Chief Financial Officer | Mar 2, 2026 | Sale | $88.93 | 7,576 | $673.7K | 237,483 | |
KYMR | Jacobs Bruce N. | — | Mar 2, 2026 | Proposed Sale | $90.10 | 12,576 | $1.1M | — | |
KYMR | BRUCE N. JACOBS | — | Sep 17, 2025 | Proposed Sale | $48.78 | 79,220 | $3.9M | — | |
KYMR | Jacobs Bruce N. | — | Mar 3, 2025 | Proposed Sale | $31.35 | 7,035 | $220.5K | — |